FI942011A0 - Transdermal therapeutic systems containing anti-crystallization agents - Google Patents

Transdermal therapeutic systems containing anti-crystallization agents

Info

Publication number
FI942011A0
FI942011A0 FI942011A FI942011A FI942011A0 FI 942011 A0 FI942011 A0 FI 942011A0 FI 942011 A FI942011 A FI 942011A FI 942011 A FI942011 A FI 942011A FI 942011 A0 FI942011 A0 FI 942011A0
Authority
FI
Finland
Prior art keywords
transdermal therapeutic
systems containing
containing anti
therapeutic systems
crystallization agents
Prior art date
Application number
FI942011A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI942011A (en
FI110061B (en
Inventor
Ralph Lipp
Jutta Riedl
Johannes Tack
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI942011A0 publication Critical patent/FI942011A0/en
Publication of FI942011A publication Critical patent/FI942011A/en
Application granted granted Critical
Publication of FI110061B publication Critical patent/FI110061B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Described is a transdermal therapeutic system which is characterized in that it includes a crystallization inhibitor, and optionally also penetration enhancers, in an adhesive matrix containing the active substance.
FI942011A 1991-10-31 1994-04-29 Process for the preparation of a transdermal therapeutic system with a crystallization inhibitor FI110061B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE4136057 1991-10-31
DE4136057 1991-10-31
DE4210711A DE4210711A1 (en) 1991-10-31 1992-03-27 TRANSDERMAL THERAPEUTIC SYSTEMS WITH CRYSTALIZATION INHIBITORS
DE4210711 1992-03-27
PCT/EP1992/002478 WO1993008795A1 (en) 1991-10-31 1992-10-21 Transdermal therapeutic systems containing crystallization inhibitors
EP9202478 1992-10-21

Publications (3)

Publication Number Publication Date
FI942011A0 true FI942011A0 (en) 1994-04-29
FI942011A FI942011A (en) 1994-04-29
FI110061B FI110061B (en) 2002-11-29

Family

ID=25908725

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942011A FI110061B (en) 1991-10-31 1994-04-29 Process for the preparation of a transdermal therapeutic system with a crystallization inhibitor

Country Status (14)

Country Link
EP (1) EP0610357B1 (en)
JP (1) JP3526864B2 (en)
AT (1) ATE158181T1 (en)
AU (2) AU2895392A (en)
CA (1) CA2120599C (en)
DE (2) DE4210711A1 (en)
DK (1) DK0610357T3 (en)
ES (1) ES2106888T3 (en)
FI (1) FI110061B (en)
GR (1) GR3025237T3 (en)
HU (1) HU227531B1 (en)
NO (1) NO307644B1 (en)
PT (1) PT101019B (en)
WO (1) WO1993008795A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JPH08512054A (en) * 1993-06-25 1996-12-17 アルザ・コーポレーション Inclusion of poly-N-vinylamide in transdermal system
DE4333595A1 (en) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermal therapeutic system for applying drugs to the skin
DE4405899A1 (en) * 1994-02-18 1995-08-24 Schering Ag Agent for transdermal application containing desogestrel
DE4429667C2 (en) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol TTS with water-binding additives and process for its preparation
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Compositions for transdermal delivery of acid-labile drugs
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
DE19500662C2 (en) * 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Plaster containing estradiol and its use
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
CA2222133C (en) † 1995-06-07 2002-12-24 Cygnus, Inc. Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
DE19526864A1 (en) * 1995-07-22 1997-01-23 Labtec Gmbh Hormone patches
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
DE19629468A1 (en) * 1996-07-11 1998-01-15 Schering Ag Transdermal therapeutic systems
DE19649535C2 (en) * 1996-11-29 2000-02-10 Lohmann Therapie Syst Lts Process for the production of a plaster-shaped therapeutic system
DE19701949A1 (en) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermal therapeutic system
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19827732A1 (en) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermal patch useful for hormone replacement therapy used for treatment of menopausal symptoms
DE19829713C1 (en) * 1998-07-03 2000-01-05 Lohmann Therapie Syst Lts Therapeutic system with the addition of pearlescent pigments
DE19834006A1 (en) * 1998-07-29 2000-02-24 Lohmann Therapie Syst Lts Estradiol-containing patch for the transdermal application of hormones
DE19843027A1 (en) * 1998-09-19 2000-03-23 Labtec Gmbh Transdermal therapeutic system used for administration of sex hormones contains neohesperidin dihydrochalcone to inhibit crystallization of active agent
DE10012908B4 (en) * 2000-03-16 2005-03-17 Lts Lohmann Therapie-Systeme Ag Stabilized supersaturated transdermal therapeutic matrix systems and methods for their preparation
DE10033853A1 (en) * 2000-07-12 2002-01-31 Hexal Ag Transdermal therapeutic system, containing highly dispersed silicon dioxide in matrix or adhesive layer to promote drug permeation through the skin
NZ530227A (en) * 2001-06-18 2006-09-29 Noven Pharma Enhanced drug delivery in transdermal systems
JP5619337B2 (en) 2003-10-10 2014-11-05 フェリング ビー．ブイ． Transdermal pharmaceutical formulation to minimize skin residue
EP1857103B1 (en) 2005-02-28 2018-10-24 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
EP2258355B1 (en) 2008-02-27 2020-01-22 Hisamitsu Pharmaceutical Co., Inc. Patch
EP2255802B1 (en) 2008-02-27 2018-01-17 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product
EP2258396B1 (en) 2008-03-03 2017-09-06 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
JP5766475B2 (en) * 2010-03-30 2015-08-19 日東電工株式会社 Patch preparation and method for producing the same
DE102010040299A1 (en) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
US9980920B2 (en) 2013-09-11 2018-05-29 Medrx Co., Ltd. Base composition for tape agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512358D0 (en) * 1985-05-16 1985-06-19 Euro Celtique Sa Transdermal delivery system
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
DE3933460A1 (en) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts OSTROGEN-ACTIVE PLASTER
WO1991005529A1 (en) * 1989-10-13 1991-05-02 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
JPH07116032B2 (en) * 1990-04-06 1995-12-13 積水化学工業株式会社 Nitroglycerin patch

Also Published As

Publication number Publication date
DE4210711A1 (en) 1993-05-06
DK0610357T3 (en) 1998-05-11
AU712692B2 (en) 1999-11-11
PT101019B (en) 1999-10-29
ATE158181T1 (en) 1997-10-15
HU227531B1 (en) 2011-07-28
HUT72964A (en) 1996-06-28
NO941593L (en) 1994-04-29
NO307644B1 (en) 2000-05-08
JPH07506083A (en) 1995-07-06
CA2120599C (en) 2003-04-15
HU9401257D0 (en) 1994-08-29
ES2106888T3 (en) 1997-11-16
AU1652997A (en) 1997-05-29
EP0610357B1 (en) 1997-09-17
CA2120599A1 (en) 1993-05-13
DE59208918D1 (en) 1997-10-23
WO1993008795A1 (en) 1993-05-13
FI942011A (en) 1994-04-29
EP0610357A1 (en) 1994-08-17
FI110061B (en) 2002-11-29
PT101019A (en) 1994-02-28
JP3526864B2 (en) 2004-05-17
GR3025237T3 (en) 1998-02-27
NO941593D0 (en) 1994-04-29
AU2895392A (en) 1993-06-07

Similar Documents

Publication Publication Date Title
FI942011A0 (en) Transdermal therapeutic systems containing anti-crystallization agents
DK0596903T3 (en) Transdermal, therapeutic systems.
DE68915413D1 (en) Active matrix display device.
DE68924247D1 (en) Active matrix display device.
MX9203755A (en) IONTOPHORETICAL SUPPLY DEVICE FOR DRUGS OR THERAPEUTIC AGENTS, EQUIPPED WITH AN ADHESIVE OF ELECTRO-TRANSPORTATION.
ATE200028T1 (en) TRANSDERMAL DELIVERY DEVICE
DE3585905D1 (en) ACTIVE MATRIX DISPLAY DEVICE.
DE69308242D1 (en) Active matrix display device
DE69109321D1 (en) Active matrix display device.
BR9609794A (en) Transdermal therapeutic system (stt)
ES2147858T3 (en) MATRIX FOR THE TRANSDERMIC SUPPLY OF PHARMACES.
AR009516A1 (en) A PRESSURE SENSITIVE ADHESIVE MATRIX PATCH DEVICE, A METHOD FOR PREPARING SUCH A DEVICE AND A METHOD FOR USING SUCH DEVICE IN THE TRANSDERMIC SUPPLY OF A DRUG.
DE69021513D1 (en) Active matrix display device.
DE69416041D1 (en) Active matrix display device
DE69221201D1 (en) Active matrix display device
DE68917651D1 (en) Active matrix display device.
DE59509084D1 (en) TRANSDERMAL PHARMACEUTICAL FORM WITH ANTIHISTAMINICALLY ACTIVE LORATIDINE METABOLITE
DE69111968D1 (en) Display device with active matrix.
DE69013610D1 (en) Active matrix display device.
ATE289818T1 (en) TRANSDERMAL THERAPEUTIC SYSTEM WITH A BISPHOSPHATE COMBINATION CONTAINING ESTRIOLE
KR900011031A (en) Thin film transistor for active matrix panel

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: BAYER INTELLECTUAL PROPERTY GMBH

MA Patent expired